Reduced TFAP2A function causes variable optic fissure closure and retinal defects and sensitizes eye development to mutations in other morphogenetic regulators.
Mutations in the transcription factor encoding TFAP2A gene underlie branchio-oculo-facial syndrome (BOFS), a rare dominant disorder characterized by distinctive craniofacial, ocular, ectodermal and renal anomalies. To elucidate the range of ocular phenotypes caused by mutations in TFAP2A, we took three approaches. First, we screened a cohort of 37 highly selected individuals with severe ocular anomalies plus variable defects associated with BOFS for mutations or deletions in TFAP2A. We identified one individual with a de novo TFAP2A four amino acid deletion, a second individual with two non-synonymous variations in an alternative splice isoform TFAP2A2, and a sibling-pair with a paternally inherited whole gene deletion with variable phenotypic expression. Second, we determined that TFAP2A is expressed in the lens, neural retina, nasal process, and epithelial lining of the oral cavity and palatal shelves of human and mouse embryos--sites consistent with the phenotype observed in patients with BOFS. Third, we used zebrafish to examine how partial abrogation of the fish ortholog of TFAP2A affects the penetrance and expressivity of ocular phenotypes due to mutations in genes encoding bmp4 or tcf7l1a. In both cases, we observed synthetic, enhanced ocular phenotypes including coloboma and anophthalmia when tfap2a is knocked down in embryos with bmp4 or tcf7l1a mutations. These results reveal that mutations in TFAP2A are associated with a wide range of eye phenotypes and that hypomorphic tfap2a mutations can increase the risk of developmental defects arising from mutations at other loci.
Gestri
Gaia
G
Department of Cell and Developmental Biology, UCL, London, UK.
Osborne
Robert J
RJ
Wyatt
Alexander W
AW
Gerrelli
Dianne
D
Gribble
Susan
S
Stewart
Helen
H
Fryer
Alan
A
Bunyan
David J
DJ
Prescott
Katrina
K
Collin
J Richard O
JR
Fitzgerald
Tomas
T
Robinson
David
D
Carter
Nigel P
NP
Wilson
Stephen W
SW
Ragge
Nicola K
NK
D000328:Adult; D000818:Animals; D019280:Branchio-Oto-Renal Syndrome / Q000235:genetics; D002675:Child, Preschool; D005123:Eye / Q000196:embryology*; D005124:Eye Abnormalities / Q000235:genetics*; D005260:Female; D017353:Gene Deletion; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009024:Morphogenesis / Q000235:genetics; D009154:Mutation; D012160:Retina / Q000002:abnormalities*; D050656:Transcription Factor AP-2 / Q000235:genetics*; D015027:Zebrafish; D029961:Zebrafish Proteins / Q000235:genetics
C493673:TFAP2A protein, human; D050656:Transcription Factor AP-2; D029961:Zebrafish Proteins; C493676:tfap2a protein, zebrafish
Mol Cell Biol. 2008 Jan;28(1):315-25
17984226
Neuron. 2005 Jul 7;47(1):43-56
15996547
Teratology. 2001 May;63(5):167-75
11320527
Nature. 2000 Oct 19;407(6806):913-6
11057671
Hum Mutat. 2009 Oct;30(10):1378-86
19708017
Nucleic Acids Res. 2008 Apr;36(7):2257-67
18285363
J Pediatr Ophthalmol Strabismus. 1992 May-Jun;29(3):177-9
1432504
Genes Dev. 2001 Jun 1;15(11):1427-34
11390362
Nucleic Acids Res. 2002 Jun 15;30(12):e57
12060695
Mol Cell Biol. 1993 Jul;13(7):4174-85
8321221
Am J Hum Genet. 2009 Mar;84(3):406-11
19249007
Nature. 1996 May 16;381(6579):235-8
8622765
Hum Mol Genet. 2009 Mar 15;18(6):1110-21
19129173
Dev Dyn. 2008 Dec;237(12):3681-9
18985738
Br J Cancer. 2004 Sep 13;91(6):1155-9
15475941
Development. 2003 Mar;130(5):955-68
12538521
Mol Vis. 2007 Jul 19;13:1215-25
17679940
Genome Biol. 2007;8(10):R228
17961237
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2236-41
19164594
Am J Med Genet A. 2009 Mar;149A(3):427-30
19206157
Nucleic Acids Res. 2003 Jul 1;31(13):3568-71
12824367
Neuron. 2002 Jul 18;35(2):255-65
12160744
Nucleic Acids Res. 2009 Jan;37(Database issue):D229-32
18978020
Dev Dyn. 1995 Jul;203(3):253-310
8589427
Dev Biol. 1999 Feb 1;206(1):46-62
9918694
Am J Med Genet. 1995 Mar 13;56(1):42-59
7747785
Mamm Genome. 2004 Jun;15(6):424-32
15181535
Nature. 1996 May 16;381(6579):238-41
8622766
Genes Dev. 1991 Jan;5(1):105-19
1989904
Dev Dyn. 2004 Jan;229(1):87-98
14699580
J Med Genet. 2003 Apr;40(4):e43
12676916
Am J Hum Genet. 2008 May;82(5):1171-7
18423521
Am J Hum Genet. 2008 Feb;82(2):304-19
18252212
J Med Genet. 1999 Sep;36(9):708-10
10507730
Dev Biol. 2007 Oct 1;310(1):71-84
17727832
Development. 2004 Apr;131(7):1463-77
14985255
Development. 2005 Apr;132(7):1737-48
15753216
Mol Cell Biol. 2009 Jan;29(1):172-86
18955504
J Med Genet. 1992 Jun;29(6):430-1
1619642
Development. 2002 Jul;129(13):3161-71
12070091
Nat Genet. 2000 Oct;26(2):216-20
11017081
Dev Biol. 2004 Jan 1;265(1):246-61
14697367
Dev Dyn. 2008 Mar;237(3):602-17
18224708
Dev Dyn. 1997 Jan;208(1):115-24
8989526
BMC Genet. 2001;2:18
11722794
Dev Dyn. 1997 Apr;208(4):516-25
9097023
Development. 2003 May;130(9):1937-47
12642497
Dev Biol. 1998 Nov 15;203(2):245-63
9808777
Dev Biol. 2007 Apr 1;304(1):338-54
17258188
Mol Cell Biol. 2007 Nov;27(21):7497-510
17724084
Nature. 2006 Nov 23;444(7118):444-54
17122850
Development. 2003 Dec;130(23):5755-68
14534133